Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.26B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.29B |
| 3 |
Eli Lilly
LLY
|
+$1.06B |
| 4 |
NVIDIA
NVDA
|
+$588M |
| 5 |
Meta Platforms (Facebook)
META
|
+$462M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$654M |
| 2 |
Apple
AAPL
|
+$459M |
| 3 |
Iris Energy
IREN
|
+$384M |
| 4 |
Micron Technology
MU
|
+$349M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$307M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.22% |
| 2 | Financials | 7.89% |
| 3 | Healthcare | 5.64% |
| 4 | Industrials | 5.33% |
| 5 | Consumer Discretionary | 4.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Citizens
CIA
$192M
| $245K | ﹤0.01% |
50,703
+16,029
| +46% | +$88.3K |
|
4802
TriSalus Life Sciences
TLSI
$345M
| $244K | ﹤0.01% |
34,914
+20,261
| +138% | +$113K |
|
4803
Flowers Foods
FLO
$1.57B
| $243K | ﹤0.01% |
22,377
+1,702
| +8% | +$19.8K |
|
|
SBR
4804
Sabine Royalty Trust
SBR
$1.05B
| $243K | ﹤0.01% |
3,546
-6,664
| -65% | -$484K |
|
|
SNWV
4805
SANUWAVE Health Inc
SNWV
$50.6M
| $243K | ﹤0.01% |
8,137
+3,828
| +89% | +$123K |
|
|
CAI
4806
Caris Life Sciences
CAI
$6.43B
| $243K | ﹤0.01% |
8,995
+7,225
| +408% | +$203K |
|
4807
PUT
Accenture
ACN
$108B
| $241K | ﹤0.01% |
900
| – | – |
|
|
TBRG
4808
DELISTED
TruBridge
TBRG
| $241K | ﹤0.01% |
10,927
+4,789
| +78% | +$100K |
|
4809
Tonix Pharmaceuticals
TNXP
$192M
| $241K | ﹤0.01% |
15,430
+8,240
| +115% | +$152K |
|
4810
FVCBankcorp
FVCB
$333M
| $241K | ﹤0.01% |
17,305
+5,469
| +46% | +$70K |
|
4811
Falcon's Beyond
FBYD
$494M
| $241K | ﹤0.01% |
+16,027
| New | +$222K |
|
4812
Alico
ALCO
$283M
| $240K | ﹤0.01% |
6,608
+1,804
| +38% | +$62.8K |
|
4813
Oportun Financial
OPRT
$372M
| $240K | ﹤0.01% |
45,414
+15,381
| +51% | +$81.1K |
|
4814
USCB Financial Holdings
USCB
$412M
| $239K | ﹤0.01% |
12,993
+5,378
| +71% | +$96.1K |
|
4815
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
$148M
| $238K | ﹤0.01% |
10,293
+1,268
| +14% | +$28.8K |
|
4816
New Fortress Energy
NFE
$101M
| $238K | ﹤0.01% |
208,755
-81,827
| -28% | -$121K |
|
4817
Rackspace Technology
RXT
$1.24B
| $238K | ﹤0.01% |
244,939
+28,885
| +13% | +$36.3K |
|
4818
FlexShares Ultra-Short Income Fund
RAVI
$1.49B
| $238K | ﹤0.01% |
3,153
+700
| +29% | +$52.8K |
|
|
GDO
4819
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.4M
| $236K | ﹤0.01% |
20,008
-4,149
| -17% | -$48.7K |
|
4820
Franklin Financial Services
FRAF
$280M
| $236K | ﹤0.01% |
4,698
+1,485
| +46% | +$73K |
|
4821
Cardiff Oncology
CRDF
$77.2M
| $236K | ﹤0.01% |
83,830
+25,311
| +43% | +$58.8K |
|
|
LOVE
4822
LoveSac
LOVE
$261M
| $235K | ﹤0.01% |
15,937
+5,755
| +57% | +$81.3K |
|
4823
JELD-WEN Holding
JELD
$164M
| $235K | ﹤0.01% |
95,472
+25,143
| +36% | +$82.6K |
|
|
DFSV
4824
Dimensional US Small Cap Value ETF
DFSV
$8.34B
| $234K | ﹤0.01% |
7,113
+6,256
| +730% | +$201K |
|
4825
Heron Therapeutics
HRTX
$92.9M
| $234K | ﹤0.01% |
179,620
+56,488
| +46% | +$69.7K |
|
Similar funds
Wells Fargo's Q4 2025 Portfolio in Review
As of Q4 2025, Wells Fargo held 7,429 positions worth $549B, up 4.4% from $526B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Wells Fargo's Q4 2025 filing shows 473 new, 3,755 increased, 1,877 reduced and 424 closed positions. Its largest new stake was Akre Focus ETF: 869,756 shares worth $57M. The largest sale was Advanced Micro Devices, an estimated $654M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Wells Fargo's largest Q4 2025 buy was Akre Focus ETF: 869,756 shares worth $57M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $7.26B increase.
- Wells Fargo's biggest Q4 2025 reduction was Advanced Micro Devices, cutting an estimated $654M.
- Wells Fargo fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $51.6M.
- Wells Fargo's ten largest holdings make up 21% of its $549B portfolio in Q4 2025.
- Wells Fargo opened 473 new positions and closed 424 in Q4 2025.
- Wells Fargo's portfolio value rose 4.4% quarter-over-quarter to $549B.
Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.